TrialPloS one2017

The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial.

Dirk Schädler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.